Synergistic Therapeutic Potential of Dexamethasone and l-arginine in Lipopolysaccharide-Induced Septic Shock
Authors:
- Sudha PremachandranSPSudha Premachandran
- Jyoti ShuklaJSJyoti Shukla
- T.B. PoduvalTPT.B. Poduval
- 1 June 2007
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 140 (1) , 99-108
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Emerging drugs for the treatment of sepsisExpert Opinion on Emerging Drugs, 2006
- NEUTRALIZATION OF TUMOR NECROSIS FACTOR IN PRECLINICAL MODELS OF SEPSISShock, 2005
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- Sepsis: An arginine deficiency state?Critical Care Medicine, 2004
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Immunomodulatory and Protective Effects of Moxifloxacin againstCandida albicans-Induced Bronchopneumonia in Mice Injected with CyclophosphamideAntimicrobial Agents and Chemotherapy, 2002
- Quantitative trait loci modulate neutrophil infiltration in the liver during LPS‐induced inflammationThe FASEB Journal, 2000
- Regulation of Genes for Inducible Nitric Oxide Synthase and Urea Cycle Enzymes in Rat Liver in Endotoxin ShockBiochemical and Biophysical Research Communications, 2000
- Pathogenesis of septic shock in Pseudomonas aeruginosa pneumoniaJournal of Clinical Investigation, 1999
- Nitric oxide in septic shockBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1999